IT

Veeda Launches New Global Oncology CRO Subsidiary

Veeda Clinical Research, a full service Global CRO, recently announced the launch of a Global Oncology CRO. The objective of setting up Veeda Oncology is to provide oncology clinical research services internationally for the pharmaceutical and biotech industries. Veeda would leverage its presence in the US, Europe and India to meet both the regional and global needs of its sponsors.

Announcing the formation of the new Global Oncology subsidiary CRO, Binoy Gardi, Group Managing Director, Veeda Clinical Research, said, "Since July 1, 2007, we have been establishing the infrastructure for a global oncology CRO and today we are pleased to announce that both the personnel and technical infrastructure are in place, validated and tested".

"I am extremely excited to fulfill a vision of Veeda to be able to provide clients with world class oncology expertise along with rapid and cost effective access to oncology/ haematology patients around the globe through our facilities in India, Europe and North America," said Matt Bowman, President and CEO of the Oncology Division.

Apurva Shah, Co- Group Managing Director, Veeda Clinical Research, said, "A key strategy that we are implementing will be our access to the oncology patient population through our unique exclusive relationships with oncology hospitals in India as well as unique relationships with oncology hospitals in Eastern Europe. In addition, our US organisation has worked with virtually every major oncology investigational site. With these relationships and the rapid ability to open sites, we will be able to meet the critical accrual requirements that our sponsors are establishing to accelerate the rate of drug development."

EH News Bureau